arginine vasopressin has been researched along with l 365209 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bock, MG; Clineschmidt, BV; Freidinger, RM; Lis, EV; Pettibone, DJ; Reiss, DR; Totaro, JA; Tung, RD; Veber, DF; Woyden, CJ | 1 |
| Anderson, PS; Clineschmidt, BV; Freidinger, RM; Goetz, MA; Hensens, OD; Koupal, LR; Lundell, GF; Pettibone, DJ; Schwartz, CD; Williamson, JM | 1 |
2 other study(ies) available for arginine vasopressin and l 365209
| Article | Year |
|---|---|
In vitro pharmacological profile of a novel structural class of oxytocin antagonists.
Topics: Amino Acid Sequence; Animals; Arginine Vasopressin; Female; Kinetics; Male; Molecular Sequence Data; Oxytocin; Peptides, Cyclic; Rats; Rats, Inbred Strains; Tritium; Uterus | 1991 |
A structurally unique, potent, and selective oxytocin antagonist derived from Streptomyces silvensis.
Topics: Animals; Arginine Vasopressin; Female; In Vitro Techniques; Liver; Oxytocin; Peptides; Peptides, Cyclic; Rats; Rats, Inbred Strains; Receptors, Angiotensin; Receptors, Oxytocin; Receptors, Vasopressin; Streptomyces; Uterus | 1989 |